Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis
Yongqi Wu(The Ohio State University), J. J. Chalmers(The Ohio State University), Clayton Deighan(The Ohio State University), Maciej Zborowski(Cleveland Clinic Lerner College of Medicine), Peter Amaya(The Ohio State University), Kyoung‐Joo Jenny Park(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Quintin Pan(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Brandon Miller(The Ohio State University)
Cited by 18
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Triple-negative breast cancer: promising prognostic biomarkers currently in development
|Expert Review of Anticancer Therapy|2020|236